	Pediatric sepsis-associated acute kidney injury: leveraging pathophysiology for risk stratification and identification of treatable traits. Pediatr Nephrol Clover-Brown I, Fuhrman DY, Stanski NL. PMID: 42493645 [PubMed - as supplied by publisher]
	Comment on: Cardiovascular and prostate cancer risk associated to testosterone replacement therapy - a systematic review and meta-analysis of 41 randomized controlled trials. Int J Impot Res Sharifan A. PMID: 42493582 [PubMed - as supplied by publisher]
	Electronic nose-based urinary volatilome profiling accurately discriminates bladder cancer from healthy controls: A prospective diagnostic study. Urol Oncol Filianoti A, Costantini M, Rosca V, Mastroianni R, Tuderti G, Ghezzo N, Simone G. PMID: 42493403 [PubMed - as supplied by publisher]
	Circulating KIM-1 and survival outcomes in renal cell carcinoma: A systematic review and meta-analysis. Urol Oncol Lu J, Luo B, Xue C, Shen J. PMID: 42493401 [PubMed - as supplied by publisher]
	Letter to the Editor Regarding "Association of Frailty and Its Trajectories With the Risk of Cardiovascular-Kidney-Metabolic Syndrome Progression: A Longitudinal Cohort Study". Geriatr Gerontol Int Shikha D, Sharma S. PMID: 42493354 [PubMed - in process]
	Re: Kitamura H, Tsukamoto T, Kakehi Y, et al. Active Surveillance Versus Intravesical Bacillus Calmette-GuÃ©rin for High-grade T1 Bladder Cancer with Negative Second Transurethral Resection: The Randomized Noninferiority Phase 3 JCOG1019 Trial. Eur Urol 2026;89:437-45. Eur Urol Di Bello F, Gallioli A, Breda A, Palou J. PMID: 42493340 [PubMed - as supplied by publisher]
	Re: James P. Buteau, Daniel Moon, Michael T. Fahey, et al. Effect of [(68)Ga]Ga-PSMA-11 PET-CT in the Diagnosis of Prostate Cancer in Men with Equivocal or Clinically High-risk Non-suspicious Findings on Multiparametric MRI (PRIMARY2): A Multicenter, Non-inferiority, Phase 3, Randomized Controlled Trial. Lancet Oncol 2026;27:839-848. Eur Urol Uleri A, Baboudjian M, Lughezzani G, Ploussard G. PMID: 42493339 [PubMed - as supplied by publisher]
	Re: Robert M. Meier, Nima Aghdam, Alan C. Beckman et al. 10-yr Survival and Toxicity Outcomes of Stereotactic Body Radiotherapy for Prostate Cancer: A Nonrandomized Clinical Trial. Eur Urol In press. http://dx.doi.org/10.1016/j.eururo.2026.04.029. Eur Urol Kim JS, Chang AR, Kim JH. PMID: 42493338 [PubMed - as supplied by publisher]
	Seeking a Credible Basis for Prostatic Obstruction as the Reversible Cause of Other Lower Urinary Tract Dysfunctions. Eur Urol Focus Drake MJ, Tikkinen KAO. PMID: 42493334 [PubMed - as supplied by publisher]
	Randomized phase II trial of nivolumab and ipilimumab with or without stereotactic body radiation therapy in patients with metastatic castration-resistant prostate cancer: the CheckPRO, CA209-8TY trial. J Immunother Cancer Eefsen RL, Spindler NJ, Theile S, Al-Farra G, Hendel HW, Lorentzen T, Fredberg Persson G, Behrens CP, Chen IM, Madsen K, Sengeløv L, Svane IM, Lindberg H, Kongsted P, Nielsen DL. PMID: 42493213 [PubMed - indexed for MEDLINE]
	Circulating kidney injury molecule-1 as a prognostic biomarker for long-term renal outcomes in lupus nephritis: a retrospective cohort study. Lupus Sci Med Sako K, Toyota Y, Nakagawa S, Yomogida D, Yoshida M, Takeji A, Yuasa T, Koshino A, Tsuge S, Yamamura Y, Oshima M, Hara S, Ito K, Sakai N, Shimizu M, Wada T, Bonventre JV, Iwata Y. PMID: 42493211 [PubMed - indexed for MEDLINE]
	Endovascular treatment of type B aortic dissection in patients with and without end-stage renal disease: A propensity-matched cohort study. Curr Probl Surg Zhang X, He H, Li M, Shu C. PMID: 42493184 [PubMed - in process]
	Outcome Prediction After [(177)Lu]Lu-PSMA I&T in Metastatic Castration-Resistant Prostate Cancer: External Validation of a [(68)Ga]Ga-PSMA-11 PET-Based Model with [(18)F]F-Flotufolastat. J Nucl Med Karimzadeh A, Fütterer C, Hansen K, Coban Ö, Hein S, Nekolla S, Heck M, Tauber R, Haller B, Gafita A, Weber WA, Eiber M, Rauscher I. PMID: 42492997 [PubMed - as supplied by publisher]
	Single-Capillary Dual Point-of-Care Testing to Support Cardio-Renal Diagnostic Decision-Making in Ambulatory Care. Ann Clin Lab Sci Pokem PN, Khatib A, Belik F, Ortega ÁM, Kaddouri IA, Draoui S, Labriola L, Devresse A, Pouleur AC, Gruson D. PMID: 42492967 [PubMed - indexed for MEDLINE]
	Early treatment with rasburicase and risk of kidney replacement therapy and death in adults with tumour lysis syndrome: emulated target trial. BMJ Shenoy T, Sanchez-Almanzar D, Dias JA, Hayden R, Shashaty MG, Aklilu AM, Patell R, Anand S, Renaghan A, Bassil C, Neyra JA, Bansal A, Shah CV, Gupta S, Sise ME, Seethapathy R, Chase S, Thompson C, Radhakrishnan R, Verma E, Ni J, Hoge ST, Lypka V, Ali R, Monson AE, Kaunfer S, Angus E, Griffiths S, Walling C, Al Haddad N, Brotman CH, Miano T, Shirali AC, Turco DJ, Alleyne SA, Shelton K, Shaefi S, Garcia D, Nasim A, Jan N, Nguyen PH, Ziolkowski S, Subramanian N, Subramanian V, Debnath N, Faldu CT, Wickramasinghe K, Donahue BP, Shah A, Shostak J, Jayakumar V, Nadayil J, Baz R, Takeuchi T, Renzi S, Rehman AU, Nombera-Aznaran N, Charkviani M, Kotzin M, Kaiser J, Edwards M, Mathavan A, Mathavan A, Obimdike F, Shah N, LaCasce AS, Armand P, Leaf DE. PMID: 42492944 [PubMed - indexed for MEDLINE]
	Fetal Growth Restriction and Acute Kidney Injury in Children and Young Adults. Kidney Int Høyer S, Heide-Jørgensen U, Nørgaard M, Henriksen TB, Carrero JJ, Christiansen CF. PMID: 42492855 [PubMed - as supplied by publisher]
	A multicenter registry study of the CD38 antibody daratumumab for the treatment of microvascular inflammation following kidney transplantation. Kidney Int Drasch T, Mayer KA, Böhmig GA, Akifova A, Halleck F, Budde K, Rohlfing D, Hinze C, Kluger M, Grahammer F, Kowald J, Baatz S, Reuter S, Kemmner S, Seibt T, Pigorsch M, Beck J, Bornemann-Kolatzki K, Schütz E, Oellerich M, Banas B, Zecher D. PMID: 42492852 [PubMed - as supplied by publisher]
	Various effects of ADAM10 and ADAM17 metalloproteases on kidney (dys)function. Biochim Biophys Acta Mol Basis Dis Typiak M, Piwkowska A. PMID: 42492839 [PubMed - as supplied by publisher]
	TREATMENT OF INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME: GUIDELINES FROM THE COMMITTEE OF FEMALE UROLOGY (CUROPF) OF THE FRENCH ASSOCIATION OF UROLOGY (AFU). Fr J Urol Meyer F, Brandon CA, Saussine C, Borojeni S, Bosset PO, Campagne-Loiseau S, Cornu JN, Donon L, Even L, Florin M, Hervé F, Klap J, Perrouin Verbe MA, Plassais C, Richard C, Vidart A, Lebdai S, Levesque A, Thuillier C, Peyronnet B. PMID: 42492794 [PubMed - as supplied by publisher]
	Biomarker-guided pharmacotherapy in cardiovascular-kidney-metabolic syndrome: A three-dimensional framework for precision drug selection and monitoring. Pharmacol Ther Li Y, Song W, Huan C, Xu K, Sun J, Zhen X, Ouyang H, Tang H, Fan Q, Zhi W, Chai Y, Li R, Wang H, Yang X. PMID: 42492739 [PubMed - as supplied by publisher]

Articles 1 - 20 / 477438

Page 1 of 23872



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy